Bunkerhill Health vs Innovaccer (2026)
Two build your own agent platforms with different foundations underneath. Bunkerhill is clinical first, with multiple clearances on its own agents, a named typed attestation and more than twenty agents running simultaneously at a named academic health system. Innovaccer builds from data connectivity upward, arguing nothing downstream works until the data is joined, and supplies both layers. If your agents will read images and draft clinical orders, Bunkerhill has the regulatory record for it. If your data is fragmented across systems, Innovaccer addresses the cause first. The shared gap is the one this model creates: both move validation of customer built agents to your quality committee, and neither publishes how such an agent should be validated or retired.
- Its agents act rather than recommend, including drafting orders for clinician review, with multiple clearances on its own agents and a named typed attestation.
- Clinical and operational teams build, deploy and govern their own agents, with more than twenty running at a named academic health system.
- The regulatory position is the strongest among provider side platform vendors in this index.
- The platform is built in stages from data connectivity upward, so the agent layer sits on a data foundation the same vendor supplies.
- It reaches population and network wide use rather than one workflow, which suits an organisation whose problem is fragmentation.
- For a system already running its data platform, agents extend an existing relationship rather than adding a vendor.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Bunkerhill Health and Innovaccer are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Bunkerhill Health | Innovaccer |
|---|---|---|
| Primary category | Health System AI Platforms | Health System AI Platforms |
| Founded | Not recorded | 2014 |
| Headquarters | San Francisco, California | San Francisco, California |
| Website | bunkerhillhealth.com | innovaccer.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Bunkerhill Health its top capability grade on AI Centrality and FDA and Regulatory Status. Set against Innovaccer, Bunkerhill Health grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Innovaccer its top capability grade on several axes, including Clinical and Operational Evidence, EHR and Interoperability Depth and Deployment Model and Data Residency. Set against Bunkerhill Health, Innovaccer grades higher on several axes, including Model Supply Chain Disclosure, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Bunkerhill Health or Innovaccer?
On the axes where the AI Health Index separates them, Bunkerhill Health grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency, and Innovaccer grades higher on several axes, including Model Supply Chain Disclosure, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Neither leads on the greater share of scored axes, so the decision turns on which constraint is binding rather than on an overall winner.
Where do Bunkerhill Health and Innovaccer differ most?
The widest separation the AI Health Index records between Bunkerhill Health and Innovaccer is on FDA and Regulatory Status, where Bunkerhill Health grades A and Innovaccer grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Bunkerhill Health and Innovaccer grade the same?
The AI Health Index grades Bunkerhill Health and Innovaccer the same on AI Governance and Bias Disclosure, AI Liability and Recourse and Commercial Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Bunkerhill Health and Innovaccer not disclosed?
At the last review, at least one of Bunkerhill Health and Innovaccer published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Both sell a layer on which a health system builds its own agents, and neither publishes how customer authored agents are validated, monitored or retired once they are running on patients, which is the governance burden this model transfers to the buyer. Neither publishes retention periods, a training use position or a de identification posture. Bunkerhill's clearances cover its own agents rather than anything a customer builds, which is the distinction to hold when reading its regulatory record.